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THE importance of using pure, inbred strains in cancer research is now
generally accepted. Strong (1942), emphasizing this point, gave a survey of the
origin of some of the best known strains, originating from his laboratory. The
new informal document, Mouse News Letter, acts as a most valuable source of
information as to a great many strains used all over the world.
The characteristics of the different strains as to susceptibility to development
of spontaneous tumours, reaction to carcingenic agents, as well as susceptibility
to transplantation and other biological responses may be very marked and very
different. It is therefore of great importance to have a great number of different
strains with marked characteristics, in order to supply research workers with the
best material possible for their special needs.
The purpose of the present paper is to describe the origin, development and
some ofthe features of our strain " White Label".
The first animals were obtained from a commercial dealer in Oslo, a young
man who used to supply a number of laboratories with albino mice, and who,
from time to time, added animals of different origin to his stock. The original
mouse was therefore a highly heterozygous animal.
Ourstrainstartedwithapregnantfemale,producingtwosonsandtwodaughters,
which again formed the first two brother-to-sister mated pairs. Since then
brother-to-sister matings have been carried out, only exceptionally the daughter
being back-crossed to the father, if a suitable brother was lacking.
Fig. 1 shows the first four generations. A few litters, indicated with small
dots, were not carried further. The figure likewise indicates theearliest deviation
of the two lines " Line 27 " and " Line 426", which will be described in some
detail later. Likewise is indicated what is supposed to be the origin of the
branch ofthe " White Label " strain, which has been kept at the University of
Leeds since May, 1934.
In a previous paper (Kreyberg, 1935) some of the features of the tumour
reactions ofthe offspring ofone ofthe two first pairs (2 + 3) have been described.
All animals were tar painted after a litter had been raised, and the tar tumour
formation as well as the occurrence of spontaneous tumours were recorded.
From this procedure a number of data were revealed, and for details the original
paper should be consulted.
In the first heterozygous generations the tar tumour reaction was irregular,
and a considerable number of mammary carcinomas, lung adenomas and quite a
number of soft part sarcomas and a few rarer tumours (osteogenic sarcoma,
hypernephroma) occurred.THE WHITE LABEL MOUSE STRAIN
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FIG. 1.-The first four generations of " White Label " and the relationship between
the Oslo and the Leeds sub-strains.
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Fig. 2 presents some of the findings, but in the chart not all of the families
areincluded. Thefigureshows, however, very clearly how two lines were develop-
ing with extreme differences as to the formation of spontaneous mammary car-
cinomas.
"Line 27 " produced a high, and anincreasinglyhigherpercentage ofmammary
tumours. From F2 and up to and including F14, when this line became extinct,
mammary tumours occurred in every generation, and from Fg until F14 16 out
of 18 females developed such tumours.
From the sister of No. 27, namely No. 26, another line was segregated, later
designated " Line 426", from the female No. 426, in Fig. 2 indicated by an arrow.
In the 11 generations (F5-F15) in which there were 102 females, not a single
instance of mammary carcinoma was observed. Such was the situation in 1935.
In the following years the brother-to-sister matings were continued and many
sidelines died out, or were not continued, but " Line 426 " was kept until the
war interrupted the experiment at F37.
In Table I is given a complete record of the females of all the generations de-
scending from pair (2 + 3) up to F37. In the first column is indicatedthe genera-
tion. Inthesecondcolumn is giventhetotalnumberoffemalesineachgeneration.
In the third column is given the number of females belonging to " Line 426";
from F15 all the females belong to this line, as this is the only line surviving.
In the fourth column is given the total number of mammary carcinomas occur-
ring in each generation. Finally the 24 columns showthenumberofanimalsdying
in each month after birth, as well as the occurrence of mammary carcinomas,
the figures in brackets. At the bottom of the table the sum total is recorded,
as well as the reversed figures, indicating the number of females alive at the end
ofeach month.
Table I gives a clear picture ofthe great number of mammary tumours occur-
ring in the first heterozygous generations. From F12 it is only " Line 27 " which
still contributes to the presentation of mammary tumours, and from F14 when
this line becomes extinct, only one single mammary tumour occurs (that is in
" Line 426 "). An exception, indicated by a cross, will be mentioned later.
This means that " Line 426", during 34 generations, comprising 1595 females,
presents one single case of mammary carcinoma. From Table I it is clearly
shown that a great many females lived long enough to have been able to develop
a mammary tumour according to the usual period of occurrence.
The one mammary tumour, indicated by a cross in Table I, occurred in one
female out of 16, belonging to generation Flg and F20, injected with folliculine
(" Ovifolline", Nyco, Oslo) in weekly doses of 500 mouse units, as previously
reported (Kreyberg, 1936).
If we now turn to the other pair of the F1 (4 + 5) we will find that a few
sarcomas occurred in the first generations. These tumours are not marked in
either ofthe tables presented. In Table II, however, the total number of females
and their life span, as well as the occurrence of mammary tumours, are recorded
in the same manner as for the first pair (2 + 3). It will be seen that in this
line a segregation of different sub-lines with marked differences did not take
place. In the total population of this line the occurrence of mammary tumours
was approximately 21 per cent, and this percentage was kept up to the F24 when
this line became extinct, due regard being taken of the small number of animals
in each generation, and the number of animals dying before the cancer age. If
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only females reaching 12 months of age or more are considered, the mammary
carcinoma frequency was approximately 35 per cent.
From several publications it will be known that a strain, designated as
"White Label," has been used in Leeds for many years, and from Leeds sent to
other laboratories. The data available clearly show a very great difference
between the Oslo andthe Leeds strains of" White Label ". As confusion may be
caused, Ifindit desirable to try and analyse these differences, and possibly explain
their background.
Dr. G. Bonser, University of Leeds, wrote me in August, 1949, regarding this
question as follows:
" I still keep 'White Label ' mice in this laboratory. By suckling offspring of low-
cancer mothers of another strain on ' White Label ' females I showed that the milk
factor was present. By suckling 'White Label' babies on RIII mothers I showed that
they were susceptible to the RIII milk factor, which I regard as a potent factor. I
never published these experiments, and they were only done on small numbers of mice,
but they point strongly to the fact that 'White Label' mice in Leeds have the milk
factor, and are susceptible to it."
Dr. Bonser wrote me a further letter in February, 1951, stating that-
" Mammary cancers still occur in ourline and we regard the incidence as being about
30 per cent in mice which live to be 12 months ofage or more, but I have not any recent
accurate estimate of the mammary cancer incidence, because we have been very short
ofaccommodation lately. .
Addition:
" Now, in 1952, we find that 7 of 33 females over 10 months of age have developed
mammary cancer, usually rather late in life. But we make no attempt to assess the
mammary cancer incidence accurately as we usually dispose of breeding females when
they reach the age of one year."
I also had the following information, dated January, 1951, from Dr. W. S.
Bullough:
" My experienoe with these mice falls into two periods. First when I was working
in the Zoology Department in Leeds and when I obtained the mice from Dr. Bonser.
Then mammary carcinoma was common in females offrom 11 months of age onwards.
I have no figures now, but my recollection is that it developed in not less than 40 per
cent of the older females. Also there was the odd occurrence in a male, though this
was of course rare."
Further:
" This colony was allowed to die out in 1944, but in 1946 I obtained two females and
a male from Dr. Bonser and started a new colony in the University of Sheffield. Since
then a colony of some 200-300 mice has been maintained. . . . Thus I have had
plenty of opportunity to observe the incidence of mammary carcinoma in older females,
and I have found it to be common-much commoner it seems than in Dr. Bonser's
parent strain in Leeds."
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Further, in 1952:
" The final chapter in the story starts in 1949 when, in the autumn, I took the milk
factor out byfostering one family with a Strong's CBA female. The family was born in
an open grid and the babies fell through into a lower compartment. My present colony
is entirely derived from this one family, and now mammary cancer is exceedingly rare.
Indeed I cannot remember when I last had a case. So my present stock of your mice
is without the milk factor, and I suppose it is no use for your own present purposes."
I regret very much that I cannot definitely state so, but I have strong reasons
to believe that the animals sent to Leeds in May, 1934, were descendants from
thepair (4 + 5) ofmy " White Label ". Thiswouldoffer a verynatural explanation
ofthe great similaritybetween the Leeds strain andoneofthe main branches ofmy
strain under development in 1934. The animals sent to Leeds probably belonged
to the F16 of this branch, described above, and the mammary tumour charac-
teristics are very similar. If this supposition is correct, it would establish a
very formal and remote relationship only between the Oslo and the Leeds strains
of" White Label ". Actually, they wouldhave only the completely heterozygous
founding mother in common.
Whereas the branch (4 + 5) has shown a remarkable stability from the very
beginning until it became extinct in Oslo but was still maintained in England,
the branch (2 + 3) at an early date started to segregate into very different lines
with gradual stabilisation of their characteristics. The present only surviving
line (426) in Oslo, through one influence or another, lost the milk factor probably
at an early date. In a series of experiments a few years ago the milk factor
was reintroduced into the Oslo " White Label " strain, through suckling a breast
cancer female of another origin.
SUMMARY.
A brief account is presented ofthe origin and the development ofthe " White
Label " strain. Starting with a pregnant heterozygous female and through subse-
quent systematic brother-to-sister matings anon-selective segregation took place,
resulting in the formation of two main branches and several lines. A description
of some of these lines is given. At present one "White Label " strain (Leeds)
carries the milkfactor and produces about 30 per cent of mammary carcinomas
in females reaching the age of 12 months or more. This strain has the char-
acteristics ofthe branch (4 + 5) ofthe original material. Another " White Label "
strain(Oslo) is devoid of the milk factor and produces practically no mammary
carcinomas spontaneously. This strain is probably one of the lowest mammary
cancer strains in existence. For future references it is therefore of great im-
portance to distinguish between these two " White Label " strains; therefore
the Leeds strain will be designated WLL and the Oslo strain WLO. The two
strains most probably have only a heterozygous founding mother in common.
This experiment has been carried out for more than twenty years. It would
not havebeen possible without the assistance ofmy collaborator Miss Hj. Aasland,
who continued the experiment during the first years of the war, until illness and
an untimely death ended her devoted and loyal partnership. During the remain-
ing years of the war the strain was maintained at a reduced scale through the
initiative and faithful service ofMrs. E. Wraal.
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